Differences in the diagnosis and treatment guidelines at home and abroad for non-al-coholic fatty liver disease and treatment prospects
10.20039/j.cnki.1007-3949.2024.04.010
- VernacularTitle:非酒精性脂肪性肝病国内外诊疗指南的区别及治疗展望
- Author:
Xiang LI
1
;
Yi CHEN
;
Xia LIU
;
Yang SUN
Author Information
1. 海军军医大学药学院,上海市 200433
- Keywords:
non-alcoholic fatty liver disease;
metabolic associated fatty liver disease;
diagnosis and treatment guidelines;
medical treatment
- From:
Chinese Journal of Arteriosclerosis
2024;32(4):347-354
- CountryChina
- Language:Chinese
-
Abstract:
Non-alcoholic fatty liver disease(NAFLD),a metabolic stress-induced liver injury,is characterized by excessive accumulation of fat in the liver,which is closely related to insulin resistance and genetic susceptibility.It is es-timated that 25％of the world's population are currently diagnosed with NAFLD,which has a huge impact on socioeconomic development and people's health.The prevalence of NAFLD in different countries/regions is different based on the living customs and population genetic differences in different regions,and there are also certain differences in the diagnostic crite-ria and treatment plans of NAFLD in the recommendations given by the national/regional diagnosis and treatment guide-lines.This article aims to compare the latest domestic and international guidelines on the diagnosis and treatment of NAFLD,as well as summarise the latest research advances in the treatment of NAFLD,in order to provide recommenda-tions for the clinical management of NAFLD.
